These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 9507998

  • 21. Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9.
    Ouguerram K, Chetiveaux M, Zair Y, Costet P, Abifadel M, Varret M, Boileau C, Magot T, Krempf M.
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1448-53. PubMed ID: 15166014
    [Abstract] [Full Text] [Related]

  • 22. Physiologic mechanisms of action of lovastatin in nephrotic syndrome.
    Aguilar-Salinas CA, Barrett PH, Kelber J, Delmez J, Schonfeld G.
    J Lipid Res; 1995 Jan; 36(1):188-99. PubMed ID: 7706943
    [Abstract] [Full Text] [Related]

  • 23. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
    Teng B, Sniderman AD, Soutar AK, Thompson GR.
    J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973
    [Abstract] [Full Text] [Related]

  • 24. In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene.
    Elias N, Patterson BW, Schonfeld G.
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1309-15. PubMed ID: 10807747
    [Abstract] [Full Text] [Related]

  • 25. Nutritional regulation of cholesterol synthesis and apolipoprotein B kinetics: studies in patients with familial hypercholesterolemia and normal subjects treated with a high carbohydrate, low fat diet.
    Stacpoole PW, von Bergmann K, Kilgore LL, Zech LA, Fisher WR.
    J Lipid Res; 1991 Nov; 32(11):1837-48. PubMed ID: 1770303
    [Abstract] [Full Text] [Related]

  • 26. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
    Davignon J, Dufour R, Roy M, Bétard C, Ma Y, Ouellette S, Boulet L, Lussier-Cacan S.
    Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645
    [Abstract] [Full Text] [Related]

  • 27. Homozygous familial defective apolipoprotein B-100. Enhanced removal of apolipoprotein E-containing VLDLs and decreased production of LDLs.
    Schaefer JR, Scharnagl H, Baumstark MW, Schweer H, Zech LA, Seyberth H, Winkler K, Steinmetz A, März W.
    Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):348-53. PubMed ID: 9081691
    [Abstract] [Full Text] [Related]

  • 28. Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production.
    Millar JS, Maugeais C, Ikewaki K, Kolansky DM, Barrett PH, Budreck EC, Boston RC, Tada N, Mochizuki S, Defesche JC, Wilson JM, Rader DJ.
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):560-5. PubMed ID: 15637307
    [Abstract] [Full Text] [Related]

  • 29. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR, Jalbert SM, Lamon-Fava S, Dolnikowski GG, Welty FK, Barrett HR, Schaefer EJ, Lichtenstein AH.
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [Abstract] [Full Text] [Related]

  • 30. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW.
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [Abstract] [Full Text] [Related]

  • 31. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
    Raal FJ, Pilcher G, Rubinsztein DC, Lingenhel A, Utermann G.
    Atherosclerosis; 1997 Feb 28; 129(1):97-102. PubMed ID: 9069523
    [Abstract] [Full Text] [Related]

  • 32. Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes.
    Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Ordovas JM, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 1997 May 28; 17(5):881-8. PubMed ID: 9157951
    [Abstract] [Full Text] [Related]

  • 33. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity.
    Pont F, Duvillard L, Florentin E, Gambert P, Vergès B.
    Arterioscler Thromb Vasc Biol; 2002 Oct 01; 22(10):1726-32. PubMed ID: 12377756
    [Abstract] [Full Text] [Related]

  • 34. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
    Chan DC, Watts GF, Barrett PH, O'Neill FH, Thompson GR.
    Obes Res; 2003 Apr 01; 11(4):591-6. PubMed ID: 12690090
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies.
    Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Ordovas JM, Schaefer EJ.
    J Lipid Res; 1997 Aug 01; 38(8):1535-43. PubMed ID: 9300775
    [Abstract] [Full Text] [Related]

  • 37. Influence of obesity on the metabolism of apolipoprotein B in humans.
    Egusa G, Beltz WF, Grundy SM, Howard BV.
    J Clin Invest; 1985 Aug 01; 76(2):596-603. PubMed ID: 4031064
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.